Skip to main content
High RiskFDAfda-F-0355-2022OTHER

Giant Eagle Diced Green Peppers, 10 oz. 283 g, Frozen bag, 12 packages per case , Best By 10/14/2023 .

Category
Units Affected
699
Recall Date
November 29, 2021
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0355-2022.

Giant Eagle, Inc., Pittsburgh, PA has initiated a recall of Giant Eagle Diced Green Peppers, 10 oz. 283 g, Frozen bag, 12 packages per case, Best By 10/14/2023 because the product tested positive for Listeriosis Monocytogenes.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0355-2022.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Giant Eagle, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0355-2022.

Giant Eagle, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Giant Eagle, Inc. Recall FAQ

Giant Eagle, Inc. is the subject of a frozen food safety report: Giant Eagle Diced Green Peppers, 10 oz. 283 g, Frozen bag, 12 packages per case , Best By 10/14/2023 .. The notice was published on November 29, 2021 by the U.S. Food and Drug Administration (FDA). Approximately 699 units are potentially affected.